Clinical Trial Update: Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating guanfacine for hyperactivity and impulsivity in children with Down syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome

Drugs mentioned

• Guanfacine (guanfacine)

Snippet

Sponsor: Rachel G. Greenberg, MD, MB, MHS | Conditions: Hyperactivity in Children With Down Syndrome, Impulsivity in Children With Down Syndrome | Phase 2 | Status: TERMINATED